Navigation Links
Global Network for Neglected Tropical Diseases Partners with IDB, PAHO to Control and Eliminate Neglected Tropical Diseases in Latin America, Caribbean
Date:9/8/2009

Global Network, at the Sabin Vaccine Institute, Provides $2.5 Million Grant to Establish a Financing Mechanism to Immediately Begin Supporting NTD Programs in the Region; Marks First Financing Partnership Developed Under Gates Foundation Grant

Washington, DC (PRWEB) September 8, 2009 -- The Global Network for Neglected Tropical Diseases announced today that it is partnering with the Inter-American Development Bank (IDB) and the Pan American Health Organization (PAHO) to launch a major effort to fight neglected tropical diseases (NTDs) plaguing more than 200 million people in Latin America and the Caribbean. To help launch this effort, the Global Network provided a $2.5 million grant to establish a financing mechanism that will immediately begin supporting NTD programs in the region.

"We are proud to be part of this extraordinary partnership to help control and eventually eliminate some of these devastating diseases from the region," said Kari Stoever, Managing Director of the Global Network. "This new partnership is the first milestone reached in developing Regional Funds under the generous Gates Foundation grant awarded to the Global Network to foster collaboration to defeat neglected tropical diseases. It also is a concrete example of how organizations and governments can work together to support new investments to reach control and elimination goals under President Obama's Global Health Initiative."

The new Regional Fund will support measures to control and eliminate NTDs, the most common infections of more than 200 million of the poorest people in the Latin American and Caribbean region. They include tens of millions of cases of intestinal worm infections, such as whipworm, large common roundworm, and hookworm, and almost 10 million cases of Chagas disease, as well as schistosomiasis, trachoma, dengue fever, leishmaniasis, lymphatic filariasis (LF), and onchocerciasis.

NTDs produce extreme poverty through their impact on children's physical and cognitive development, pregnancy outcome and worker productivity. However, with a firm commitment from the public and private sectors, it is possible to eliminate onchocerciasis, lymphatic filariasis and trachoma throughout the region as well as schistosomiasis in the Caribbean.

Ultimately, the roadmap for the control and elimination of the more widespread NTDs will require an inter-sectoral approach that bridges public health, social services, and environmental interventions. The IDB has been a leader in championing this approach through its efforts to create new linkages between water and sanitation projects and public health programs.

###

Read the full story at http://www.prweb.com/releases/2009/09/prweb2844964.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Global Financial Crisis a Key Driver in Market Conditions for Property, Casualty, and Directors and Officers Lines, Says Aon
2. Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma
3. SYGNIS to Present at the 11th Rodman & Renshaw Annual Global Investment Conference
4. Reportlinker Adds Liver Disease Treatments: The Global Market Report
5. Reportlinker Adds Anti-aging Products and Services: The Global Market Report
6. Reportlinker Adds Botanical and Plant-Derived Drugs: Global Markets Report
7. Reportlinker Adds Dermatological Therapeutics: Global Markets Report
8. Reportlinker Adds Biologic Imaging Reagents: Technologies and Global Markets Report
9. ALPHARx to Present at Rodman Renshaw Annual Global Investment Conference
10. Echo Therapeutics to Present at Rodman & Renshaw 2009 Annual Global Investment Conference
11. Hologic to Present at the 2009 Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... An educational campaign aimed at everyone ... courtesy of awareness-driven celebrities and thought leaders. It also provides insight to the ... leaders such as Bioness. , As patients feel increasingly concerned about the ...
(Date:5/27/2016)... ... May 27, 2016 , ... Beleza Medspa has initiated ... regulations. This is the first time that Coolsculpting is being used for for ... six months to ensure they meet the prescribed body-fat standard, measured by the circumference-based ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and ... stories, which come courtesy of leaders in the nursing and health care industry. It ... advocates and associations—namely Abilene Christian University. , As the nursing industry is coming ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... trusted name in the pharmaceutical, medical and food industries. Aside from its GMP ... certification (SIC), providing proof of successfully certified products, services and staff. , Validation ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways ... and Sausage Council (NHDSC) suggests that Americans prefer their dogs straight off the grill. ... say grilling is their favorite way to cook a hot dog, far outpacing other ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Kitov Pharmaceuticals ... late-stage drug development, today announced the completion of ... batches required for registration of KIT-302 with the ... Kitov,s announcement in December 2015, that ... primary efficacy endpoint. "We are fortunate ...
(Date:5/26/2016)... May 26, 2016 A key ... is the emergence of new treatments. Cardax, a development ... osteoarthritis treatment. The therapy is expected to fulfil large ... UK is conducting studies to develop new treatments for ... the genes involved in osteoarthritis are being investigated, and ...
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
Breaking Medicine Technology: